Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 19 studies | 25% ± 10% | |
astrocyte | 11 studies | 37% ± 15% | |
oligodendrocyte precursor cell | 7 studies | 38% ± 14% | |
epithelial cell | 6 studies | 25% ± 9% | |
endothelial cell of lymphatic vessel | 6 studies | 31% ± 9% | |
type I pneumocyte | 6 studies | 20% ± 5% | |
glutamatergic neuron | 5 studies | 36% ± 20% | |
adipocyte | 5 studies | 21% ± 2% | |
GABAergic neuron | 5 studies | 34% ± 15% | |
interneuron | 4 studies | 31% ± 19% | |
mesothelial cell | 3 studies | 21% ± 3% | |
ciliated cell | 3 studies | 19% ± 5% | |
endothelial cell of vascular tree | 3 studies | 33% ± 14% | |
cholangiocyte | 3 studies | 36% ± 27% | |
natural killer cell | 3 studies | 18% ± 1% | |
club cell | 3 studies | 18% ± 3% | |
basal cell | 3 studies | 26% ± 7% | |
goblet cell | 3 studies | 25% ± 8% | |
vein endothelial cell | 3 studies | 40% ± 23% | |
neuron | 3 studies | 27% ± 9% | |
oligodendrocyte | 3 studies | 18% ± 2% | |
endothelial cell of artery | 3 studies | 25% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 31% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4990.70 | 1445 / 1445 | 100% | 36.23 | 183 / 183 |
uterus | 100% | 3941.98 | 170 / 170 | 100% | 30.94 | 458 / 459 |
brain | 100% | 9529.53 | 2640 / 2642 | 99% | 59.80 | 700 / 705 |
thymus | 100% | 7166.11 | 653 / 653 | 99% | 37.63 | 600 / 605 |
lung | 100% | 6160.90 | 577 / 578 | 99% | 32.18 | 1144 / 1155 |
prostate | 100% | 4223.04 | 245 / 245 | 98% | 19.73 | 494 / 502 |
breast | 100% | 5822.79 | 459 / 459 | 98% | 24.04 | 1100 / 1118 |
intestine | 100% | 3619.10 | 966 / 966 | 98% | 23.30 | 517 / 527 |
stomach | 100% | 4224.31 | 359 / 359 | 98% | 23.21 | 280 / 286 |
bladder | 100% | 3952.57 | 21 / 21 | 96% | 23.63 | 486 / 504 |
kidney | 100% | 6601.49 | 89 / 89 | 96% | 18.41 | 868 / 901 |
ovary | 100% | 3053.37 | 180 / 180 | 95% | 22.24 | 410 / 430 |
pancreas | 96% | 2119.71 | 314 / 328 | 98% | 30.08 | 174 / 178 |
skin | 100% | 5459.59 | 1807 / 1809 | 93% | 17.27 | 438 / 472 |
adrenal gland | 100% | 3612.57 | 258 / 258 | 90% | 15.92 | 207 / 230 |
liver | 97% | 2404.04 | 219 / 226 | 90% | 12.87 | 366 / 406 |
adipose | 100% | 6250.18 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 21.74 | 80 / 80 |
spleen | 100% | 4225.43 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.48 | 1 / 1 |
blood vessel | 100% | 6472.48 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 2615.61 | 816 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 18.82 | 27 / 29 |
peripheral blood | 87% | 2672.26 | 812 / 929 | 0% | 0 | 0 / 0 |
muscle | 42% | 668.01 | 341 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0050766 | Biological process | positive regulation of phagocytosis |
GO_0003014 | Biological process | renal system process |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0043114 | Biological process | regulation of vascular permeability |
GO_0007165 | Biological process | signal transduction |
GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
GO_0065002 | Biological process | intracellular protein transmembrane transport |
GO_0050885 | Biological process | neuromuscular process controlling balance |
GO_0060313 | Biological process | negative regulation of blood vessel remodeling |
GO_2000378 | Biological process | negative regulation of reactive oxygen species metabolic process |
GO_0048872 | Biological process | homeostasis of number of cells |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0060216 | Biological process | definitive hemopoiesis |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0043312 | Biological process | neutrophil degranulation |
GO_0035023 | Biological process | regulation of Rho protein signal transduction |
GO_0007264 | Biological process | small GTPase-mediated signal transduction |
GO_1905517 | Biological process | macrophage migration |
GO_1905522 | Biological process | negative regulation of macrophage migration |
GO_0002692 | Biological process | negative regulation of cellular extravasation |
GO_0006909 | Biological process | phagocytosis |
GO_0043314 | Biological process | negative regulation of neutrophil degranulation |
GO_0048041 | Biological process | focal adhesion assembly |
GO_0042472 | Biological process | inner ear morphogenesis |
GO_0007420 | Biological process | brain development |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0006468 | Biological process | protein phosphorylation |
GO_0060268 | Biological process | negative regulation of respiratory burst |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005829 | Cellular component | cytosol |
GO_0014069 | Cellular component | postsynaptic density |
GO_0030424 | Cellular component | axon |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BCR |
Protein name | Breakpoint cluster region protein BCR BCR activator of RhoGEF and GTPase Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26) BCR protein F-box domain-containing protein |
Synonyms | BCR1 D22S11 |
Description | FUNCTION: Protein with a unique structure having two opposing regulatory activities toward small GTP-binding proteins. The C-terminus is a GTPase-activating protein (GAP) domain which stimulates GTP hydrolysis by RAC1, RAC2 and CDC42. Accelerates the intrinsic rate of GTP hydrolysis of RAC1 or CDC42, leading to down-regulation of the active GTP-bound form . The central Dbl homology (DH) domain functions as guanine nucleotide exchange factor (GEF) that modulates the GTPases CDC42, RHOA and RAC1. Promotes the conversion of CDC42, RHOA and RAC1 from the GDP-bound to the GTP-bound form . The amino terminus contains an intrinsic kinase activity . Functions as an important negative regulator of neuronal RAC1 activity (By similarity). Regulates macrophage functions such as CSF1-directed motility and phagocytosis through the modulation of RAC1 activity . Plays a major role as a RHOA GEF in keratinocytes being involved in focal adhesion formation and keratinocyte differentiation . . |
Accessions | Q6QJE8 Q6QJE5 Q12844 Q6QJE4 H0Y554 Q6QJE7 Q6QJE3 P11274 ENST00000359540.7 [P11274-2] Q12843 Q5XJ20 A0A2X0SFQ7 Q6QJE6 Q6QJE9 Q12845 ENST00000427791.1 ENST00000305877.13 [P11274-1] |